The Cost of Atrial Fibrillation: A Systematic Review.

Buja, Alessandra, Rebba, Vincenzo, Montecchio, Laura, Renzo, Giulia, Baldo, Vincenzo, Cocchio, Silvia, Ferri, Nicola ORCID: 0000-0001-8898-7441, Migliore, Federico, Zorzi, Alessandro ORCID: 0000-0002-3578-0583, Collins, Brendan ORCID: 0000-0002-3023-8189
et al (show 6 more authors) (2024) The Cost of Atrial Fibrillation: A Systematic Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 27 (4). pp. 527-541.

Access the full-text of this item by clicking on the Open Access link.


<h4>Objectives</h4>Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an increasing incidence and prevalence because of progressively aging populations. Costs related to AF are both direct and indirect. This systematic review aims to identify the main cost drivers of the illness, assess the potential economic impact resulting from changes in care strategies, and propose interventions where they are most needed.<h4>Methods</h4>A systematic literature search of the PubMed and Scopus databases was performed to identify analytical observational studies defining the cost of illness in cases of AF. The search strategy was based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 recommendations.<h4>Results</h4>Of the 944 articles retrieved, 24 met the inclusion criteria. These studies were conducted in several countries. All studies calculated the direct medical costs, whereas 8 of 24 studies assessed indirect costs. The median annual direct medical cost per patient, considering all studies, was €9409 (13 333 US dollars in purchasing power parities), with a very large variability due to the heterogeneity of different analyses. Hospitalization costs are generally the main cost drivers. Comorbidities and complications, such as stroke, considerably increase the average annual direct medical cost of AF.<h4>Conclusions</h4>In most of the analyzed studies, inpatient care cost represents the main component of the mean direct medical cost per patient. Stroke and heart failure are responsible for a large share of the total costs; therefore, implementing guidelines to manage comorbidities in AF is a necessary step to improve health and mitigate healthcare costs.

Item Type: Article
Uncontrolled Keywords: Humans, Atrial Fibrillation, Hospitalization, Cost of Illness, Health Care Costs, Stroke
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Population Health
Depositing User: Symplectic Admin
Date Deposited: 02 Feb 2024 08:05
Last Modified: 12 Apr 2024 16:27
DOI: 10.1016/j.jval.2023.12.015
Open Access URL:
Related URLs: